Integrative Analysis of Wilson's Disease
威尔逊病的综合分析
基本信息
- 批准号:8387888
- 负责人:
- 金额:$ 40.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAcute Liver FailureAffectAnimal ModelAnimalsBiochemicalBrainBrain MassBrain regionCell NucleusCell modelCellsCopperCytosolDevelopmentDiagnosticDiseaseDown-RegulationEarly DiagnosisElectron MicroscopyEnvironmentEquilibriumEventFatty AcidsFluorescenceGene Expression ProfileGenesGenotypeGlutathioneGlutathione DisulfideHepaticHepatolenticular DegenerationHereditary DiseaseHomeostasisHumanImmunohistochemistryImpairmentLabelLeadLinkLipidsLiteratureLiverLongitudinal StudiesMaintenanceMass Spectrum AnalysisMeasuresMediatingMessenger RNAMetabolicMetabolic PathwayMetabolismMethodologyModelingMolecularMolecular AnalysisMusMutateMutationNeurologicNeurologic ManifestationsNeurologic SymptomsNeuronsNuclear ProteinsOxidation-ReductionPathologicPathologyPathway interactionsPatientsPatternPhenotypeProcessProteinsRNARNA SplicingRNA-Binding ProteinsRoentgen RaysRoleSeverity of illnessSpectrum AnalysisStagingSymptomsTestingTimeTissuesTranscriptUp-RegulationVariantWilson disease proteinabsorptionbasebehavior changebehavior testcell behaviorcell growthcell injuryglutathione peroxidasehnRNP A2insightinterdisciplinary approachlipid biosynthesislipid metabolismliver transplantationmetalloenzymemind controlmyelinationoxidationresearch studyresponsesensorsmall hairpin RNAtrafficking
项目摘要
DESCRIPTION (provided by applicant): The long term of this study is to provide detailed mechanistic understanding of Wilson's disease (WD). WD is a severe and potentially fatal human disorder of copper homeostasis, caused by mutations in the copper transporter ATP7B. The disease is associated with copper overload in tissues, particularly in the liver, and a wide spectrum of hepatic, neurologic, and psychiatric abnormalities. Currently, specific molecular pathways through which copper triggers WD are poorly understood. The proposed studies will use a multidisciplinary approach based on modern methodologies to identify biochemical and cellular events that lead to the onset and progression of WD. The experiments measuring oxidation state of glutathione and proteins will determine whether in WD copper acts by modifying the redox environment of cellular compartments (Specific Aim 1). The role of hnRNP A2 in cell response to copper overload will be determined by characterizing its intracellular localization, interacting proteins, and a subset of transcripts affected by hnRNPA2 up-regulation (Specific Aim 2). Metabolic changes in the brain of Atp7b-/- mice will be characterized by corelating time-dependent copper distribution with changes in lipids and mRNA profiles at different stages of the disease (Specific Aim 3). Cell injury and behavior changes will be evaluated in conjunctions with analysis of molecular and metabolic changes.
PUBLIC HEALTH RELEVANCE: The project focuses on elucidating the mechanisms of pathology development in Wilson's disease, a severe genetic disorder in humans with hepatic and neurologic manifestations. The studies will identify key molecular factors and proceses that underlie the development and progresion of pathologic changes in Wilson's disease. The results will contribute to improvement of diagnostic and treatment of this potentially fatal disorder of copper metabolism.
描述(由申请人提供):本研究的长期目的是详细了解威尔逊氏病(WD)的机制。WD是一种严重且可能致命的人类铜稳态紊乱,由铜转运体ATP7B突变引起。该疾病与组织中铜超载有关,特别是在肝脏中,以及广泛的肝脏、神经和精神异常。目前,铜触发WD的具体分子途径尚不清楚。拟议的研究将使用基于现代方法的多学科方法来确定导致WD发病和进展的生化和细胞事件。测量谷胱甘肽和蛋白质氧化状态的实验将确定在WD中铜是否通过改变细胞区室的氧化还原环境起作用(Specific Aim 1)。hnRNPA2在细胞对铜超载反应中的作用将通过表征其细胞内定位、相互作用蛋白和受hnRNPA2上调影响的转录子子集来确定(Specific Aim 2)。Atp7b-/-小鼠大脑中的代谢变化将通过将时间依赖性铜分布与疾病不同阶段的脂质和mRNA谱变化相关来表征(Specific Aim 3)。细胞损伤和行为改变将结合分子和代谢变化的分析来评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SVETLANA LUTSENKO其他文献
SVETLANA LUTSENKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SVETLANA LUTSENKO', 18)}}的其他基金
HUMAN DISORDERS OF COPPER METABOLISM: RECENT ADVANCES AND MAIN CHALLENGES
人类铜代谢紊乱:最新进展和主要挑战
- 批准号:
8459097 - 财政年份:2013
- 资助金额:
$ 40.18万 - 项目类别:
Molecular Physiology and Biochemistry of Wilson's disease
威尔逊病的分子生理学和生物化学
- 批准号:
8086727 - 财政年份:2010
- 资助金额:
$ 40.18万 - 项目类别:
THE STRUCTURE OF THE N-NUCLEOTIDE BINDING DOMAIN OF WILSON'S DISEASE ATPASE
威尔逊病ATP酶的N-核苷酸结合域的结构
- 批准号:
7420569 - 财政年份:2006
- 资助金额:
$ 40.18万 - 项目类别:
Characterization of nuclear proteome in normal and diseased liver
正常和患病肝脏中核蛋白质组的表征
- 批准号:
7134091 - 财政年份:2006
- 资助金额:
$ 40.18万 - 项目类别:
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 40.18万 - 项目类别:
Hepatocytes Encapsulated with mesenchymal stromal cells in alginate microbeads for the treatment of acute Liver failure in Paediatric patients (HELP)
将间充质基质细胞封装在藻酸盐微珠中的肝细胞用于治疗儿科患者的急性肝衰竭(HELP)
- 批准号:
MR/V038583/1 - 财政年份:2022
- 资助金额:
$ 40.18万 - 项目类别:
Research Grant
Development of the innovative treatment using self iPS cell for acute liver failure
开发利用自身 iPS 细胞治疗急性肝衰竭的创新疗法
- 批准号:
21K08685 - 财政年份:2021
- 资助金额:
$ 40.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10421290 - 财政年份:2021
- 资助金额:
$ 40.18万 - 项目类别:
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)
小儿急性肝衰竭免疫反应网络 (PALF IRN):免疫介导的病理生理学治疗 (TRIUMPH)
- 批准号:
10180251 - 财政年份:2021
- 资助金额:
$ 40.18万 - 项目类别:
Therapeutic effect of plasmacytoid dendritic cells transplantation for acute liver failure
浆细胞样树突状细胞移植治疗急性肝衰竭的疗效
- 批准号:
20K21607 - 财政年份:2020
- 资助金额:
$ 40.18万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Macrophage Therapy for Acute Liver Failure
巨噬细胞治疗急性肝衰竭
- 批准号:
MR/T044802/1 - 财政年份:2020
- 资助金额:
$ 40.18万 - 项目类别:
Research Grant
Investigation of an optimal environment for the proliferation of mature hepatocytes toward the rescue of acute liver failure patients
研究成熟肝细胞增殖的最佳环境以挽救急性肝衰竭患者
- 批准号:
19K08475 - 财政年份:2019
- 资助金额:
$ 40.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)
小儿急性肝衰竭 (PALF) 免疫介导病理生理学治疗 (TRIUMPH)
- 批准号:
9789253 - 财政年份:2018
- 资助金额:
$ 40.18万 - 项目类别:
Cryopreservation of hiPS-derivd hepatic progenitor cells and application to acute liver failure treatment
hiPS源性肝祖细胞的冷冻保存及其在急性肝衰竭治疗中的应用
- 批准号:
18K08662 - 财政年份:2018
- 资助金额:
$ 40.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)